甲索特雷克萨特可以作为一种选择,用于管理初始高β-人类胆道性淋巴腺激素水平的女性的异位妊娠?
Sherin Hassaballa1, Ahmed Abdelmohsen1, Paul Armstrong1
1Obstetrics and Gynaecology, William Harvey Hospital, East Kent Hospitals University NHS Foundation Trust, Ashford, GBR.
Cureus
|December 8, 2025
概括
本案例研究探讨了当患者拒绝标准治疗时,如何管理子宫外妊娠. 在咨询后,甲托雷克萨特可能是另一种选择,但持续性质量需要进一步研究.
科学领域:
- 产科和妇科 产科和妇科
- 生殖医学 生殖医学
背景情况:
- 宫外妊娠是一个常见的临床挑战.
- 对于标准管理,存在基于证据的指导方针.
- 患者拒绝标准治疗需要替代方法.
研究的目的:
- 介绍患者拒绝标准护理后异胎妊娠的病例管理.
- 在这种情况下,分析解决方案的时间和患者的观点.
- 根据知情咨询,探索甲状腺素作为潜在的替代治疗方法.
主要方法:
- 审查国家卫生和护理卓越研究所 (NICE) 和美国妇产科医生学院 (ACOG) 的指导方针.
- 对已发表的关于美托特雷克萨特在异卵性怀孕中有效性的研究进行了评估,其中包括具有不同β-人类胆性淋巴激素 (β-hCG) 水平的研究.
- 在产科管理中分析患者知情选择.
主要成果:
- 详细介绍了病例管理,解决时间和患者的观点.
- 在彻底的患者咨询的背景下,讨论了甲托雷克萨特的潜在作用.
- 突出了临床解决方案后持续性子宫外质量的重要性.
结论:
- 知情的患者选择是现代产科实践的一个关键方面.
- 在接受了全面的咨询后,甲托雷克萨特可能是选择患者的可行选择.
- 需要进一步的研究来评估管理持续性子宫外质量的好处和风险.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
Ovarian Cycle
3.3K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461


